Protalix Biotherapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Protalix Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protalix Biotherapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protalix Biotherapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $889k | 400k | 2.22 |
| 2025-06-30 | $734k | 496k | 1.48 |
| 2025-03-31 | $1.2M | 483k | 2.56 |
| 2023-12-31 | $126k | 71k | 1.78 |
| 2023-09-30 | $278k | 168k | 1.66 |
| 2023-06-30 | $231k | 116k | 2.00 |
| 2023-03-31 | $333k | 159k | 2.10 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management